{
    "code": 0,
    "data": [
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of Q3 FY 26 for the Earnings Conference Call held on January 19 2026.",
            "news_id": "3583c177-8afc-4c6d-987f-6f7910de9652",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fdf47fd1-c97d-4b4a-9207-336c0cd9f82d.pdf",
            "news_date": "2026-01-23 19:56:08",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Conference Call for Q3 FY 26.",
            "news_id": "bfdc8a2c-6fdb-4a56-99dc-e2634e6b70e5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a511da7-4d9d-4886-8500-9663de853d0f.pdf",
            "news_date": "2026-01-19 18:37:45",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of Q3 & 9M FY26- Earnings Presentation.",
            "news_id": "986bcf1e-aefc-4103-9423-96e14f002da7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=845f5929-f435-44d2-97f8-efe265495347.pdf",
            "news_date": "2026-01-18 16:01:16",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Nine Months Ended December 31 2025.",
            "news_body": "Unaudited Financial Results (Standalone & Consolidated) for the quarter and nine months ended December 31 2025.",
            "news_id": "fe32e51b-5f4e-4762-9d3d-d6e09b2a85d4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f9bf25a3-e618-4935-831b-3ad703a06e5f.pdf",
            "news_date": "2026-01-17 16:07:16",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of Q2 FY 26 for the Earnings Conference Call held on October 17 2025.",
            "news_id": "d2ab4544-01f6-47fe-80bd-7b631084f5e1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e817dc3-1737-4f6e-82e1-e8c573f5d0c9.pdf",
            "news_date": "2025-10-27 19:35:06",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Conference call for Q2 FY 26.",
            "news_id": "12ed1bf0-9f23-4584-9955-d5fca9b66a0c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8f5a873-747c-45b1-9e12-38b79f522d3b.pdf",
            "news_date": "2025-10-17 18:52:16",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of Q2 & H1 FY26 -Earnings Presentation.",
            "news_id": "4cb99cf5-267a-424b-8f9b-8e7044581197",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26fcb99d-61d3-49d9-984b-a58a424b9bd6.pdf",
            "news_date": "2025-10-16 16:34:28",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Half Year Ended September 30 2025.",
            "news_body": "Unaudited Financial Results(Standalone & Consolidated) for the quarter and half year ended September 30 2025",
            "news_id": "e7a37118-e70f-45bd-b3f6-69b9238818e4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c0e722d9-8a7c-4f96-b9f0-64c180541e3e.pdf",
            "news_date": "2025-10-15 21:04:54",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of Q1 FY 26 for the Earnings Conference Call held on July 21 2025.",
            "news_id": "206323e7-716e-4bef-8f97-b14a8dcbf928",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f331ad5b-c905-4ace-a715-baa359eaf89e.pdf",
            "news_date": "2025-07-25 15:36:28",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Conference call for Q1 FY 26.",
            "news_id": "fef131fa-c165-4274-900b-c8ba62e1b203",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc4e76f5-59ee-4555-8dd3-5b2cbdd55b79.pdf",
            "news_date": "2025-07-21 18:57:11",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of Q1 FY 26- Earnings Presentation.",
            "news_id": "ce90ebee-0deb-4387-bb97-2405b0e7be6b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=90423203-077e-4f63-a104-2b207631ed5b.pdf",
            "news_date": "2025-07-20 15:32:31",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30 2025.",
            "news_body": "Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30 2025.",
            "news_id": "90ab6f8b-9892-467f-a9b4-d58e43eb77b2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d92cddd9-9e67-4ead-aa2d-57387d8e9e77.pdf",
            "news_date": "2025-07-19 20:31:48",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of Q4 FY 25 for the Earnings Conference Call held on April 28 2025.",
            "news_id": "1500803f-b98d-45cb-9817-22664d41acd1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5b0ff25-3178-4b5a-b023-80d4aa6e7e14.pdf",
            "news_date": "2025-05-05 20:00:24",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Conference call for Q4 FY25.\r\n",
            "news_id": "b0e77462-3b0b-4286-b571-4367b047703e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=78a577eb-6caa-4141-b815-f4fbd32d0dfc.pdf",
            "news_date": "2025-04-28 20:32:23",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of Q4 FY 25 - Earnings Presentation.",
            "news_id": "522afbcc-f646-4400-80a6-23f1eba0c10f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=117b9536-8cbe-46a8-98fc-1974e72d1db7.pdf",
            "news_date": "2025-04-26 23:24:03",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results (Standalone And Consolidated) For The Quarter And Financial Year Ended March 31 2025.",
            "news_body": "Audited Financial Results(Standalone and Consolidated) for the quarter and financial year ended March 31 2025.",
            "news_id": "b59f2302-8e89-46b7-8a27-6b84ca7888c4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8261f937-8244-470c-8f32-4276fdada835.pdf",
            "news_date": "2025-04-25 21:11:48",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of Conference call for Q3 FY 25 held on January 23 2025.",
            "news_id": "8805bd7a-d6a2-43d3-849b-15d7edc3552f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31ac5ec2-5424-4c13-8fcd-ef9ccc9392b2.pdf",
            "news_date": "2025-01-28 19:45:49",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of Q3 FY 25 - Earnings Presentation.",
            "news_id": "826a6564-d383-487b-a6bc-9054a51ffb0f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=484acb2b-b9ba-41a9-afbf-dcc6a9aef183.pdf",
            "news_date": "2025-01-22 20:20:46",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31 2024.",
            "news_body": "Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31 2024.",
            "news_id": "a7cdeb40-39b5-4aa6-80af-89effd26bd70",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d7fb0245-6b96-4f35-b63a-1133007b5298.pdf",
            "news_date": "2025-01-21 19:09:15",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript for Q2 FY25",
            "news_id": "fdcb8448-d662-4516-9480-e45599c34aab",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d96ddf06-d3a0-4cdf-ae1c-985798225f79.pdf",
            "news_date": "2024-10-25 22:39:41",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recordings of Earnings Conference Call Q2 FY25",
            "news_id": "f7f94f63-6f69-436e-b0c7-0fc514df9bf1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da4888dd-d239-486b-8364-e421a281edde.pdf",
            "news_date": "2024-10-21 20:02:03",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation Q2 H1 FY 25 (Readable format)",
            "news_id": "bce9d255-280a-46a1-b58e-aec8a8125fe0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0fae57ef-62dd-4c3a-a2ce-e48b30d8f5e9.pdf",
            "news_date": "2024-10-20 15:32:29",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Earnings Presentation for Q2 H1 FY25",
            "news_id": "10164ae8-422e-4c84-bd1a-6b8a6944cb4e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e5e3d388-a15c-498b-9427-5418b7252be6.pdf",
            "news_date": "2024-10-20 12:55:15",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30, 2024 - (Readable)",
            "news_body": "Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2024 - (Readable)",
            "news_id": "fd16f9ef-010e-48ed-8a05-061b8555fea5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f0ed1646-8737-4369-b77b-7d6fb3039f9c.pdf",
            "news_date": "2024-10-19 16:40:07",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30, 2024.",
            "news_body": "The Board of Directors of have inter alia approved the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September, 30, 2024.",
            "news_id": "fd5ab9c2-f00d-4b2f-a2cc-adf768b781e4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa08db5c-c93f-432d-84c7-dbfe8b2bcc4f.pdf",
            "news_date": "2024-10-19 15:24:37",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of Q1 FY 25 for the Earnings Conference Call held on July 22, 2024.",
            "news_id": "5ea48e88-bc0f-48e6-b557-71de87200cde",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4f5e4e94-fbca-40f6-84f4-8dd463e78e6b.pdf",
            "news_date": "2024-07-26 19:29:50",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Conference call for Q1 FY25",
            "news_id": "daa9d441-5351-4b8b-987b-5a304117ed60",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dc0a5538-9729-43ba-80b9-69c276c5cb32.pdf",
            "news_date": "2024-07-22 23:25:52",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of Q1 FY 25 - Earnings Presentation.",
            "news_id": "4c6cf574-115e-4a9a-8bd8-023c9f595a24",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e850e40b-0c79-405b-afed-9ac0701cc3a7.pdf",
            "news_date": "2024-07-21 13:28:59",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome For Outcome Of Board Meeting Held On July 20, 2024",
            "news_body": "The Board of Directors have inter alia approved the Unaudited Financial Results (Standalone and Consolidated) for the Quarter ended June 30, 2024.",
            "news_id": "4ebcb2c5-6d21-4534-9044-831c5492a1d4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=25e9d5da-3199-40e9-83de-1a1812b72c78.pdf",
            "news_date": "2024-07-20 19:33:52",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of Q4 FY 24 for the Earnings Conference Call held on April 30, 2024",
            "news_id": "e10da42b-a750-4cb8-8eb1-deb057fe47b5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09d45a5b-ddda-4f0c-8d04-692fc1d63370.pdf",
            "news_date": "2024-05-07 23:21:33",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio recording of Earnings Conference call for Q4 FY 24",
            "news_id": "e3764e53-f451-4f51-994d-d416dd9bad2f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=45d8337c-62e5-4921-ac92-566d977a2a6e.pdf",
            "news_date": "2024-04-30 18:43:19",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of Q4 FY 24 - Earnings Presentation.",
            "news_id": "8e06aa23-3c5a-4241-bf92-08da394e19b2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3f52e0c8-943a-49e6-8d98-2ff9a56c2146.pdf",
            "news_date": "2024-04-30 13:09:58",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results And Statements (Standalone And Consolidated) For The Quarter And Financial Year Ended March 31, 2024.",
            "news_body": "Audited Financial Results and Statements (Standalone and Consolidated) for the Quarter and Financial Year ended March 31, 2024.",
            "news_id": "8b86b313-a10e-4e23-b525-a8d87a99d4af",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=68beeebe-0dd5-4e5c-94bf-a7ed41c5ba99.pdf",
            "news_date": "2024-04-29 19:26:17",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "The Board of Directors have inter alia approved the Audited Financial Results and Statements (Standalone and Consolidated) for the Quarter and Financial Year ended March 31, 2024 and Final Dividend for the Financial Year 2023-24.",
            "news_id": "4c5fd862-18e2-4325-aa7b-4c142ab36933",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=65cebd3c-c57b-409d-b2dc-1dbc67d5e04e.pdf",
            "news_date": "2024-04-29 19:19:24",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of Q3 FY 24 for the Earnings Conference Call held on 23 January, 2024.",
            "news_id": "b12f0eda-d840-4c79-b4ae-1343d3e04887",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=20faac65-efdc-480a-a614-72cac44e65e7.pdf",
            "news_date": "2024-01-30 15:47:05",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings Conference Call for Q3 FY24",
            "news_id": "6fce045f-3cf4-4b03-ba29-4a41da292564",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3cdb2724-8f6f-4a52-b1b7-1931bae81530.pdf",
            "news_date": "2024-01-23 22:51:21",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of Q3 FY24- Earnings Presentation.",
            "news_id": "89ba3a15-4b05-48a6-8bd6-664abf11c564",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=47de23ac-e506-405c-9d14-3d15570bdec2.pdf",
            "news_date": "2024-01-21 16:23:45",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Rossari Biotech Limited Has Informed The Exchange Regarding Board Meeting Held On January 20, 2024.",
            "news_body": "The Board of Directors of the Company at their meeting held on January 20, 2024, have interalia approved the Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2023. (Revised)",
            "news_id": "f5780233-046c-4c1d-a2f5-ca5e25ef2a81",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=716a3087-0f56-4af6-b435-6ca0ddcbd13a.pdf",
            "news_date": "2024-01-20 18:20:12",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of transcript of the Q2 and H1 FY24 Earnings Conference Call held on October 23, 2023",
            "news_id": "51db1667-2d12-4158-9642-946bbf9070b8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=854680f7-1791-455a-9a1e-670b504660ef.pdf",
            "news_date": "2023-10-27 17:47:25",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings Conference Call for Q2 FY24",
            "news_id": "479f3f22-03f5-4745-ba23-840ac7519ee2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6236f35e-7e41-4d0e-97bd-253415462306.pdf",
            "news_date": "2023-10-25 11:29:24",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of Q2 FY24- Earning Presentation.",
            "news_id": "f6440050-c6d2-45a9-89a3-7c045be6808d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b1231a7d-f2ec-437d-81ca-08c7aa960eb3.pdf",
            "news_date": "2023-10-22 13:32:32",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting-21.10.2023",
            "news_body": "The Board of Directors have interalia approved Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September, 2023 and other matters.",
            "news_id": "dd652c74-e1bb-4167-a418-ab2804aaaf1e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0248d754-5087-4116-a7bc-f7f9b0be4951.pdf",
            "news_date": "2023-10-21 15:02:37",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Unaudited Financial Results For Quarter And Half Year Ended September 30, 2023",
            "news_body": "The Board of Directors have Inter alia approved Unaudited Financial Results (Standalone and Consolidated) for the Quarter and half year ended September 30, 2023 of the Financial Year 2023-24 and other matters.",
            "news_id": "ce4a2b76-aa12-405b-a456-2a2a418d31ed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=07771473-c87d-44d0-b15c-fd181ae3f938.pdf",
            "news_date": "2023-10-21 14:58:54",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of the Q1 FY24 Earnings Conference Call held on July 31, 2023",
            "news_id": "36bdef92-3ae7-4a69-b510-7e1abee1d47b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb8e48e6-7f20-4efd-a302-31c783655efd.pdf",
            "news_date": "2023-08-04 11:48:03",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings Conference call for Q1 FY24",
            "news_id": "89162acf-4eae-4345-8e71-3b3026171221",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=041a1343-2b35-4b24-8d79-1ec9d4a4e04d.pdf",
            "news_date": "2023-07-31 19:29:39",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of Q1 FY24 Earnings Presentation",
            "news_id": "5a39a20c-4b5c-4756-9d81-f269e9f430a4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2dda4eec-215f-472a-8845-d1f8062e5d6d.pdf",
            "news_date": "2023-07-29 22:07:13",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday, July 29, 2023",
            "news_body": "The Board of Directors have Inter alia approved Unaudited Financial Results (Standalone and Consolidated) for the Quarter ended June 30, 2023 of the Financial Year 2023-24 and other matters.",
            "news_id": "93235012-1b99-4165-98f1-f7d9ed1844f0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b4b36c29-e7e9-4958-bccb-0fae218777c5.pdf",
            "news_date": "2023-07-29 14:40:37",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of the Q4 FY23 Earnings Conference Call held on May 02, 2023",
            "news_id": "d39ea824-74d6-4611-bfe5-7f4993637c0b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a42320d0-b89f-476a-9b6f-1c862c0a7a71.pdf",
            "news_date": "2023-05-08 19:24:04",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings Conference call for Q4 FY23",
            "news_id": "ae9b5f51-5e15-4818-8ba1-0eba4994face",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=268e965f-0df6-467f-a9ff-4948ff025c16.pdf",
            "news_date": "2023-05-02 20:45:21",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of Q4 & FY23 Earnings Presentation.",
            "news_id": "a99f909b-4efa-4316-a4f1-da801bfca3c6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=798fe4b6-ceee-4fdd-9ce6-53f2d4152e46.pdf",
            "news_date": "2023-04-30 16:10:19",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On Saturday, April 29, 2023",
            "news_body": "The Board of Directors have Inter alia approved Audited Financial Results (Standalone and Consolidated) for the Quarter and Financial Year ended March 31, 2023 of the Financial Year 2022-23 and other matters.",
            "news_id": "039cb02a-3534-46dd-8558-2b0397086194",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d2a8804f-eafc-4ac4-a1ab-469104bef5d0.pdf",
            "news_date": "2023-04-29 16:52:24",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of the Q3 FY23 Earnings Conference Call held on February 06, 2023",
            "news_id": "29e11aa2-12df-442d-8625-e5913f06bd81",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea636412-66b2-4ef6-95b2-9294678fca1a.pdf",
            "news_date": "2023-02-10 17:57:39",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings Conference call for Q3 FY23",
            "news_id": "0fdd1a4d-83b0-4131-8695-3b2a6b8ffa15",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=535ad374-9e3c-4af0-8e1c-d765d60b07b7.pdf",
            "news_date": "2023-02-06 18:55:35",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of revised Q3 & 9M FY23 Earnings Presentation",
            "news_id": "36e31f68-56a6-49fc-9835-c529161c5f08",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a312ebfa-a6d0-4944-a660-677895d281e3.pdf",
            "news_date": "2023-02-05 16:04:59",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q3 & 9M FY23 Earnings Presentation",
            "news_id": "8bfe4e03-bd01-4793-b715-5396b553af38",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=568fb915-f0ff-4c41-8714-ad58f770acd5.pdf",
            "news_date": "2023-02-05 11:02:45",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On February 04, 2023",
            "news_body": "The Board has inter alia approved Un-audited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2022 for the Financial Year 2022-23 and other matters.",
            "news_id": "b5f680b8-64fb-403a-b638-23e5ce7f280c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c54462d-19bc-440c-91a9-ceb0cc4450a7.pdf",
            "news_date": "2023-02-04 15:53:54",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On February 04, 2023",
            "news_body": "The Board has inter alia approved Un-audited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2022 for the Financial Year 2022-23 and other matters.",
            "news_id": "e73e487e-a8f1-4ea2-b901-19feff6e535b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a564f902-9ef9-43f4-b130-b782cf14d59c.pdf",
            "news_date": "2023-02-04 14:55:38",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure On Related Party Transactions On Consolidated Basis For The Half Year Ended September 30, 2022",
            "news_body": "Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the disclosure of Related Party Transactions on a consolidated basis, in the prescribed format, for the half year ended September 30, 2022.",
            "news_id": "1c5bbe66-a4be-40cc-9fe3-6da413771bcf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=617806ce-d95f-4435-bd53-73111b43c83b.pdf",
            "news_date": "2022-11-18 19:46:33",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of the Q2 & FY23 Earnings Conference Call held on November 07, 2022",
            "news_id": "56939c52-ee40-4814-87b5-98ad12b6719e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e806c2a7-b5b2-4924-a987-0937ef544d48.pdf",
            "news_date": "2022-11-11 20:44:09",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings Conference call for Q2 & FY23",
            "news_id": "64292af2-6dd0-40aa-bb12-f690e37ccf1c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=473d1917-2c10-4b99-85f9-d762a5b0920b.pdf",
            "news_date": "2022-11-07 14:40:19",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q2 & FY23 Earnings Presentation",
            "news_id": "dbc5e3b4-cd04-4d34-9dfb-11bb12f42556",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a47cc0db-a4d7-40b1-a0fd-f5a725476d31.pdf",
            "news_date": "2022-11-05 23:48:16",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On November 05, 2022",
            "news_body": "The Board has inter alia approved Un-audited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2022 for the Financial Year 2022-23 and other matters.",
            "news_id": "d265d1fa-80c6-468c-a649-44c851a36bcc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cda9f5db-1e68-4f82-a84f-50e5e6eddffe.pdf",
            "news_date": "2022-11-05 14:35:36",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of the Q1 & FY23 Earnings Conference Call held on August 09, 2022",
            "news_id": "2d8f9157-8ea8-4a82-8713-757bca452ea4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=10ad1c43-c4b3-4ad7-a18d-1282c08834c1.pdf",
            "news_date": "2022-08-16 17:53:04",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q1 & FY23 Earnings Presentation",
            "news_id": "38221b3c-e3b7-4614-827d-3625f7d03833",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=234097bf-8a15-4d6e-a7bd-9b2dbdbd30fa.pdf",
            "news_date": "2022-08-07 12:07:46",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome Of Meeting Held On August 06, 2022",
            "news_body": "The Board has inter alia approved Un-audited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2022 of the Financial Year 2022-23.",
            "news_id": "b9f078cc-6711-4a31-b6a2-675af040dad8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae8d1705-edac-45dc-a985-a11de3375d8e.pdf",
            "news_date": "2022-08-06 16:06:00",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Board Meeting Outcome Of Meeting Held On August 06, 2022",
            "news_body": "The Board has inter alia approved Un-audited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2022 of the Financial Year 2022-23.",
            "news_id": "de91defd-766b-4c32-aa0d-f423206f594e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fad60919-55ab-4076-b6cd-2da04133c18c.pdf",
            "news_date": "2022-08-06 16:04:00",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure On Related Party Transactions On Consolidated Basis For The Half Year Ended March 31, 2022",
            "news_body": "Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the disclosure of Related Party Transactions on a consolidated basis, in the prescribed format, for the half year ended March 31, 2022.",
            "news_id": "579798e5-2f1d-468e-831a-fb300d579b7c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a319d607-bb41-4cdf-92cb-fbc307b8eb85.pdf",
            "news_date": "2022-06-02 20:37:34",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of the Q4 & FY22 Earnings Conference Call held on May 23, 2022",
            "news_id": "6e775d18-0ef3-49e3-a16a-cd9eaea54cdf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ce6fb66a-7168-4e6e-b36f-2cb7760a0866.pdf",
            "news_date": "2022-05-27 12:46:28",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of revised Q4 & FY22 Earnings Presentation",
            "news_id": "5b969b0c-bd38-4611-9933-3268636e7cfd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f176d4f0-717a-4a78-82e7-cab039a431a5.pdf",
            "news_date": "2022-05-24 19:37:29",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Earnings Conference call for Q4 & FY22",
            "news_id": "800e02bf-ff62-4797-a4c9-6bbe098569cf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2a335d13-c163-4969-8f5f-756f675ca5ee.pdf",
            "news_date": "2022-05-23 21:15:19",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of Q4 & FY22 Earnings Presentation",
            "news_id": "f5947064-74f5-48da-abb4-880fc32aceae",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bbd6418e-1741-4f32-b1a0-165841c70f85.pdf",
            "news_date": "2022-05-20 20:01:14",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On Thursday, May 19, 2022",
            "news_body": "The Board of Directors have Inter alia approved Audited Financial Results (Standalone and Consolidated) for the Quarter and Financial Year ended March 31, 2022 of the Financial Year 2021-22 and other matters.",
            "news_id": "95ef731b-6925-4bfc-9fb2-40c7751b0281",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=460049ca-33e8-4eed-9428-1854938453be.pdf",
            "news_date": "2022-05-19 23:26:56",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of the Q3 & 9M FY22 Earnings Conference Call held on February 15, 2022",
            "news_id": "1561d1dc-7ad2-4752-a9cf-6e4838c5f8c2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5f75b4b6-95d4-412e-88cb-b274c840827e.pdf",
            "news_date": "2022-02-28 18:54:10",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q3 & 9M FY22 Earnings Presentation",
            "news_id": "b5bdf1f7-efab-4ea5-8800-cdd18b479b0a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=089d488c-52f4-4c49-8d8c-e7fc654d68bb.pdf",
            "news_date": "2022-02-14 22:43:44",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On February 14, 2022",
            "news_body": "The Board has inter alia approved Un-audited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2021 of the Financial Year 2021-22.",
            "news_id": "daa8445b-f327-4396-b9b9-ab0f6c75621b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=659bdc7b-9f2d-4e22-93ac-bf9cecc01bfb.pdf",
            "news_date": "2022-02-14 17:19:45",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of the Q2 FY2022 Earnings Conference Call held on November 01, 2021<BR>",
            "news_id": "28b742c1-3607-47be-90b4-f49e91615218",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2a99d01c-a9ed-4cd3-87e8-4d4ead7fbd0d.pdf",
            "news_date": "2021-11-12 16:26:49",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q2 FY22 Earnings Presentation",
            "news_id": "ffdbc24e-0c92-4eb1-b3ad-613155a21516",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4c875304-d94c-4c41-8def-d0f877edbf0e.pdf",
            "news_date": "2021-10-30 22:44:36",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On October 30, 2021",
            "news_body": "The Board has Inter alia approved the following: <BR> <BR> 1. Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2021. <BR>  <BR> 2. Appointment of Mr. Ketan Sablok as Group Chief Financial Officer.<BR> <BR> 3. Appointment of Mr. Debashish Vanikar as Chief Executive Officer - New Businesses.<BR> <BR> 4. Grant of Options under Rossari Employee Stock Option an - 2019.<BR>",
            "news_id": "f838e4cc-3e0c-4a74-8a4f-c5245cb51738",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=24cfd362-ba7b-419d-bbd9-aad3ef9ab768.pdf",
            "news_date": "2021-10-30 16:24:18",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of the Q1 FY2022 Earnings Conference Call held on August 02, 2021",
            "news_id": "84a9b4f0-f05d-42e1-8195-4c7226701666",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=44b7c8da-eb19-4649-9477-04670f0fe397.pdf",
            "news_date": "2021-08-13 21:14:37",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Analysts/Institutional Investor Meet/Con. Call Update",
            "news_id": "3c8be8a9-a58d-4a17-aaf3-69ffbf605498",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=67831d1f-06d2-480e-8399-99a71ba495de.pdf",
            "news_date": "2021-08-13 20:25:30",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of Q1 & FY22 Earnings Presentation<BR>",
            "news_id": "243764b8-7659-4860-9536-7465688f560d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=10713117-e65c-4ae1-b49a-aac498c65eb1.pdf",
            "news_date": "2021-07-31 10:05:29",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On July 30, 2021",
            "news_body": "Inter alia approved Un-audited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2021 of the Financial Year 2021-22.",
            "news_id": "fa45543e-d944-46d0-a247-a4c21faa3115",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=91bd0eae-91a7-47eb-b7eb-434545041d12.pdf",
            "news_date": "2021-07-30 17:32:13",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of the Conference Call held on July 19, 2021",
            "news_id": "8618f1ee-5db6-4747-ae83-f74635435ab9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4d3fd779-3c3c-4dea-9517-b307754dcefb.pdf",
            "news_date": "2021-07-26 18:09:26",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of the Conference Call held on June 02, 2021",
            "news_id": "473ddc7c-79a2-4beb-88ba-7cc3b796ec6e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8b01c3b2-d800-460e-887a-7d348ba1a7bf.pdf",
            "news_date": "2021-06-14 14:52:51",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of Transcript of the Q4 FY2021 Earnings Conference Call held on May 17, 2021",
            "news_id": "f6675a72-15bf-4a47-9e7b-a0b02a7a5c52",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=02adf6b4-9582-40c6-ae14-a977ee76b395.pdf",
            "news_date": "2021-05-26 16:58:02",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimation of Q4 & FY21 Earnings Presentation",
            "news_id": "0ca1f774-a8ac-48a3-b424-011d659e582e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=827b9e27-6d00-4d20-b269-476b7599a617.pdf",
            "news_date": "2021-05-15 09:08:22",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ROSSARI",
            "disp": "Rossari Biotech",
            "bse_code": 543213,
            "isin": "INE02A801020",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On Friday, May 14, 2021",
            "news_body": "The Board of Directors have Inter alia approved Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2021 of the financial year 2020-21 and other matters.",
            "news_id": "71c6298b-ca3e-4a9c-8403-819a8eb2f9c6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6462f0da-e8e1-4370-a023-5a4af527a9c8.pdf",
            "news_date": "2021-05-14 18:45:57",
            "seo": "rossari-biotech-ltd",
            "ltp": 543.8,
            "ch": -2.4500000000000455,
            "pch": -0.4485125858123653,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 19410,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}